Eric Curtis

Eric Curtis

Chief Operating Officer presso WINDTREE THERAPEUTICS, INC.

Patrimonio netto: 5 636 $ in data 31/03/2024

56 anni
Health Technology
Consumer Services
Health Services

Profilo

Eric L.
Curtis
currently works at Windtree Therapeutics, Inc., as Chief Operating Officer & Senior Vice President from 2020.
Mr. Curtis also formerly worked at Centurion BioPharma Corp., as President & Chief Executive Officer, LadRx Corp., as President & Chief Operating Officer from 2018 to 2020, Aegerion Pharmaceuticals, Inc., as President-US Commercial from 2014 to 2016, and Bayer HealthCare, as Vice President & General Manager-Rare Disease from 2012 to 2014.
Mr. Curtis received his undergraduate degree from the University of Pittsburgh and Masters Business Admin degree in 1999 from The Pennsylvania State University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
16/04/2024 15 920 ( 0.19% ) 5 636 $ 31/03/2024

Posizioni attive di Eric Curtis

SocietàPosizioneInizio
WINDTREE THERAPEUTICS, INC. Chief Operating Officer 09/03/2020
Tutte le posizioni attive di Eric Curtis

Precedenti posizioni note di Eric Curtis

SocietàPosizioneFine
LADRX CORPORATION President 08/03/2020
AEGERION PHARMACEUTICALS, INC. Corporate Officer/Principal 01/01/2016
Corporate Officer/Principal 01/01/2014
Centurion BioPharma Corp. Chief Executive Officer -
Vedi nel dettaglio l'esperienza di Eric Curtis

Formazione di Eric Curtis

University of Pittsburgh Undergraduate Degree
The Pennsylvania State University Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Eric Curtis

Relazioni

100 +

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
LADRX CORPORATION

Health Technology

WINDTREE THERAPEUTICS, INC.

Health Technology

Aziende private3

Health Technology

Health Services

Centurion BioPharma Corp.

Vedi le connessioni aziendali